roxatidine
Selected indexed studies
- Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders. (Drugs, 1991) [PMID:1717223]
- Pharmacokinetic characteristics of roxatidine. (J Clin Gastroenterol, 1989) [PMID:2572622]
- A review of the animal pharmacology of roxatidine acetate. (Drugs, 1988) [PMID:2905247]
_Worker-drafted node — pending editorial review._
Connections
roxatidine is a side effect of
Sources
- Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders. (1991) pubmed
- Pharmacokinetic characteristics of roxatidine. (1989) pubmed
- A review of the animal pharmacology of roxatidine acetate. (1988) pubmed
- Interaction of roxatidine acetate with antacids, food and other drugs. (1988) pubmed
- Clinical characteristics of roxatidine acetate: a review. (1988) pubmed
- Roxatidine inhibits fibrosis by inhibiting NF‑κB and MAPK signaling in macrophages sensing breast implant surface materials. (2020) pubmed
- Roxatidine attenuates mast cell-mediated allergic inflammation via inhibition of NF-κB and p38 MAPK activation. (2017) pubmed
- Pharmacokinetics and Bioequivalence Studies of Roxatidine Acetate Hydrochloride Sustained-Release Capsule in Healthy Chinese Subjects. (2022) pubmed
- Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure. (1988) pubmed
- Roxatidine in duodenal ulcer. (1995) pubmed